At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 50 enrolled
Drug / intervention
Litramine +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Double-blind, Randomized, Placebo-controlled Clinical Investigation to Evaluate the Safety and Efficacy of Litramine in Maintaining Body Weight Loss in Overweight and Obese Subjects
In Brief
A Phase 4 clinical trial evaluating Litramine and Placebo for Weight Maintenance and 2 related conditions. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The effect of Litramine on weight loss has previously been studied during a 12-week intervention period with promising results. The present study looks into the effect of weight maintenance using Litramine following initial weight loss, for a longer period of 24 weeks.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWeight Maintenance, Overweight, Obese
CountriesGermany
Collaborators--
Timeline
Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2012
First PostedJan 2012
Primary CompletionSep 2012
TodayJul 2026
First PostedJan 6, 2012
Enrollment StartJan 1, 2012
Primary CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 14.5 years ago
Interventions
Litraminedietary
Fibre complex of plant origin in tablet form 2 tablets 3 times daily (oral consumption, after meal)
Placebodietary
Identical to Litramine tablets 2 tablets 3 times daily (oral consumption, after meal)